Eurocor Tech - Life Sciences Technologies Interventional Cardiology Devices Endovascular Therapies

Dediacted to Your heart.
Life Sciences Technology.
Coronary stent technologies and special cardiovascular and endovascluar devices made in Europe for the world.

IROS 2017

Date: 2017/02/01

IROS 2017 - Interventionell Radiologisches Olbert Symposium, Berlin, Germany, January 12 - 14, 2017

IROS 2017 (Dreiländer-Tagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Interventionelle Radiologie) took place from January 12th – 14th, 2017 in Berlin, Germany.

Congress Venue: bcc Berlin Congress Center, Alexanderstraße 11, 10178 Berlin

Click for Official site of

Eurocor scientific program

Poster Safari, January 13th, 13:15 – 14:00, Poster Terminals
Poster: 1802.3
The randomized Freeway Stent Study completed the 6 months follow up and favors the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segment to lower restenosis rate

The Company:

Eurocor is a rapidly growing European Life Sciences Technology Corporation specializing in the research, development and manufacture of cardiovascular and endovascular products. Eurocor provides interventional physicians with innovative coronary stent technologies and special cardiovascular and endovascular devices, manufactured in Bonn. Products are indicated for minimally invasive cardiovascular and peripheral surgery and comply with biological and biomechanical principles to offer highly flexible, adaptable solutions. Extensive research and development, close clinician collaboration, outstanding quality standard philosophy and global scientific alliances lead to optimization of clinically effective technologies. Eurocor has designed an innovative method for balloon catheter drug delivery with high patient compliance. One heartbeat ahead® – with innovative products such as DIOR® and FREEWAY™.
Eurocor GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Limited and is part of the Opto Circuits Group.
For more information, please visit and